Literature DB >> 17061445

[Hypertension in polycystic ovary syndrome].

L Ben Salem Hachmi1, S Ben Salem Hachmi, C Bouzid, N Younsi, H Smida, R Bouguerra, C Ben Slama.   

Abstract

UNLABELLED: Polycystic ovary syndrome (PCOS) is associated with multiple cardiovascular risk factors. The aims of this study are to investigate the prevalence of hypertension in a female population with PCOS and to correlate hypertension with her clinical and hormonal profile.
MATERIALS AND METHODS: it is a transversal study of 79 PCOS patients with mean age of 25 +/- 7 years (range 13-44). PCOS diagnosis is made by Rotterdam consensus criteria's (2003). WHO definition of hypertension is used (BP 140/90 mmHg). Blood pressure is measured three times in each patient. Ovarian echography and biochemical assays (GnRH test, androgens, cholesterol, triglycerides, and oral glucose tolerance test) are made before the 5th day of the menstrual cycle.
RESULTS: 12% of PCOS women have hypertension. Family history of hypertension is not a predictive factor of hypertension in our study. PCOS patients with hypertension are not significantly older than those without hypertension (28.4 +/- 6.5 vs. 25.2 +/- 7; p = 0.12). If compared to PCOS women without hypertension, those with hypertension have a significantly higher BMI (39.2 +/- 7 vs. 29.6; p = 0.0004). PCOS patients with and without hypertension do not differ significantly in their level of androgens and total cholesterol. Triglycerides level is higher in PCOS patients with hypertension (p = 0.06). In oral glucose tolerance test, areas under the curve of insulin and glucose are significantly higher in PCOS patients with hypertension (respectively p = 0.06 and 0.02). The area under the curve of LH during GnRH test is lower in PCOS patients with hypertension (p = 0.04).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17061445

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  5 in total

Review 1.  Diagnosis and challenges of polycystic ovary syndrome in adolescence.

Authors:  Sophia E Agapova; Tamara Cameo; Aviva B Sopher; Sharon E Oberfield
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

2.  Lack of Association of Vitamin D Receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) Genetic Variations with Polycystic Ovary Syndrome Risk: a Case-control Study from Iranian Azeri Turkish Women.

Authors:  Morteza Bagheri; Isa Abdi Rad; Nima Hosseini Jazani; Fariba Nanbakhsh
Journal:  Maedica (Buchar)       Date:  2012-12

3.  Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya; A Retrospective study.

Authors:  Fi Najem; Rr Elmehdawi; Am Swalem
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

4.  Cardiovascular Risk in Women With PCOS.

Authors:  Pietro Scicchitano; Ilaria Dentamaro; Rosa Carbonara; Gabriella Bulzis; Annamaria Dachille; Paola Caputo; Roberta Riccardi; Manuela Locorotondo; Cosimo Mandurino; Marco Matteo Ciccone
Journal:  Int J Endocrinol Metab       Date:  2012-09-30

Review 5.  Endothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseases.

Authors:  Yu-Hsun Kao; Wan-Chun Chiu; Ming-I Hsu; Yi-Jen Chen
Journal:  Int J Fertil Steril       Date:  2013-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.